Educational Agenda<strong>ACG</strong> <strong>Southern</strong> <strong>Regional</strong> <strong>Postgraduate</strong> CourSaturday, December 7, 20136:45 am Registration Opens/Breakfast in the Exhibit Hall7:40 am Welcome and Announcements<strong>Course</strong> Co-DirectorsSESSION I: ENDOSCOPY/PANCREATICOBILIARYModerators: Douglas G. Adler, MD, F<strong>ACG</strong>Ronald E. Pruitt, MD, F<strong>ACG</strong>7:45 am Options for Endoscopic Treatment of Barrett’sEsophagusPatrick S. Yachimski, MDUnderstand current recommendations toendoscopically treat Barrett’s with or withoutdysplasia.8:05 am Endoscopic Emergencies – When to Get Outof Bed in the Middle of the NightJohn R. Saltzman, MD, F<strong>ACG</strong>Identify emergencies such as foreign bodyremoval, cholangitis, and GI bleeding whichrequire more immediate attention.8:25 am Enteral Stenting – State of the Art: Benign orMalignant, We Have a Stent for YouDouglas G. Adler, MD, F<strong>ACG</strong>Apply the best options for endoscopicstenting in the pancreaticobiliary, esophageal,small bowel, and large bowel areas.8:45 am Evaluation and Management of CysticLesions of the Pancreas: When to Resect,When to Follow and When to ForgetRandall E. Brand, MD, F<strong>ACG</strong>Determine the most appropriate course ofaction to take when managing cystic lesionsof the pancreas.9:05 am Prevention of Post-ERCP Pancreatitis: IsPlacement of a PD Stent Now Standard ofCare?Glen A. Lehman, MD, F<strong>ACG</strong>Establish potential methods of preventingpost-ERCP pancreatitis, including the role ofplacing a PD stent.9:25 am Q & A9:45 am Break/Visit ExhibitsSESSION II: UPPER GI/FUNCTIONALModerator: Michael F. Vaezi, MD, PhD, F<strong>ACG</strong>10:15 am Recurrent Nausea and Vomiting: Not Only, ButAlso GastroparesisThomas L. Abell, MDTreat the disorders that present as recurrentnausea and vomiting (cyclic vomiting,cannabis hyperemesis syndrome, rumination,vestibular dysfunction, and gastroparesis).10:35 am Extra-esophageal Manifestations of GERDMichael F. Vaezi, MD, PhD, F<strong>ACG</strong>Analyze the extra-esophageal manifestationsof GERD and develop a management plan.10:55 am Celiac Disease and Non-celiac GlutenSensitivityPeter H. R. Green, MD, F<strong>ACG</strong>Specify the clinical features and diagnosticapproach to the patient with suspected celiacdisease as well as non-celiac gluten sensitivity.11:15 am Q & ASESSION III: LOWER GIModerator: Irving M. Pike, MD, F<strong>ACG</strong>11:25 am Optimization of the Exam and QualityIndicators in ColonoscopyIrving M. Pike, MD, F<strong>ACG</strong>Identify techniques to improve the quality ofyour colonoscopic examination, and evaluatewhether you and your practice are satisfyingthe new quality parameters.11:45 am Diagnosis and Management ofC. difficile Colitis: Immunocompetent andImmunocompromised PatientsChristina M. Surawicz, MD, M<strong>ACG</strong>Recognize differences in the diagnosisand treatment of C. difficile colitis inimmunocompetent and immunocompromisedpatients.12:05 pm Hereditary CRC: Practical ApproachBrandie Leach, MS, CGCIdentify the clinical clues suggestive thatyour patient has a hereditary CRC disorder,and determine which pathology and geneticstudies are needed to support your impressionand to counsel the family.12:25 pm Q & A
se • December 7-8, 2013 • Omni Nashville Hotel, Nashville, Tennessee12:45 pm Lunch Presentation: Affordable HealthcareAct – Effects on Your PracticeHarry E. Sarles, Jr., MD, F<strong>ACG</strong><strong>ACG</strong> PresidentProvide an update on current health policy.1:30 pm Dessert/Break in the Exhibit HallSIMULTANEOUS BREAKOUT SESSIONS & HANDS-ON WORKSHOPSAttendees should use the registration form to indicatewhether they would like to attend a breakout session ORhands-on workshop for each time slot. Each breakoutsession includes a case presentation and Q & A session.Space is limited for each session.Please note: Hands-on sessions provide a valuable learningopportunity for attendees, though no CME will be provided.2:00 pm to 2:45 pmCurrent Management of Alcoholic HepatitisCraig J. McClain, MD, F<strong>ACG</strong>Determine severity assessment and therapy for alcoholichepatitis (nutrition, drugs, and interventions that could helpdecrease alcohol abuse relapse).Management of Obesity for the Gastroenterologist: Nutrition,Drugs, and Surgery ReferralStephen A. McClave, MDDescribe the basis for diet counseling, drug therapy andsurgical options to treat the obese patient.ORHands-on Workshop (see registration form for options)3:00 pm to 3:45 pmPractical Tips for Managing IBD PatientsFrancis A. Farraye, MD, MSc, F<strong>ACG</strong>Discuss various scenarios of caring for IBD patients toobtain practical tips to put into practice.GI BleedingJohn R. Saltzman, MD, F<strong>ACG</strong>Review the current evaluation and management strategiesfor GI bleeding and assess current endoscopic therapeuticmodalities.ORHands-on Workshop (see registration form for options)4:00 pm to 4:45 pmCurrent Management of Alcoholic HepatitisCraig J. McClain, MD, F<strong>ACG</strong>Management of Obesity for the Gastroenterologist: Nutrition,Drugs, and Surgery ReferralStephen A. McClave, MDORHands-on Workshop (see registration form for options)5:00 pm to 5:45 pmPractical Tips for Managing IBD PatientsFrancis A. Farraye, MD, MSc, F<strong>ACG</strong>GI BleedingJohn R. Saltzman, MD, F<strong>ACG</strong>ORHands-on Workshop (see registration form for options)Sunday, December 8, 20137:00 am Breakfast in the Exhibit Hall7:55 am Welcome and Announcements<strong>Course</strong> Co-DirectorsSESSION IV: LIVERModerator: Luis S. Marsano, MD, F<strong>ACG</strong>8:00 am Current and Evolving Treatment of HCVPaul J. Pockros, MD, F<strong>ACG</strong>Assess the use of boceprevir and telaprevir,with pegylated interferon and ribavirinin patients with HCV, as well as the noninterferonbased therapies.8:25 am Current Treatment of HBVMitchell L. Shiffman, MD, F<strong>ACG</strong>Understand the use of anti-HBV drugsaccording to the immune stage of HBV;to minimize transmission risk duringpregnancy; and to prevent reactivation ofoccult HBV during immunosuppression.8:50 am Management of the Cirrhotic Patient:Minimizing ComplicationsLuis S. Marsano, MD, F<strong>ACG</strong>Specify management techniques that canimprove outcomes in cirrhotic patients:early interventions in nutrition, hepaticencephalopathy, variceal bleeding, ascitescontrol, and renal dysfunction.9:15 am Management of NAFLDCraig J. McClain, MD, F<strong>ACG</strong>Understand the diagnostic and therapeuticapproach for early detection and control ofhepatic and non-hepatic complications inpatients with NAFLD.9:40 am Q & A10:00 am Break/Visit ExhibitsSESSION V: INFLAMMATORY BOWEL DISEASEModerator: David A. Schwartz, MD, F<strong>ACG</strong>10:30 am Immunizations and Health Maintenance inChronic GI DisordersFrancis A. Farraye, MD, MSc, F<strong>ACG</strong>Identify which vaccines and other healthprevention measures are useful in patientswith chronic GI disorders – IBD or cirrhosis.10:55 am Personalized Medicine in IBD: Where AreWe in 2013?David A. Schwartz, MD, F<strong>ACG</strong>Understand how your patient’s genomecan affect clinical evolution and treatmentchoices in IBD.11:20 am Severe IBD: What to Do When Anti-TNFsDon’t WorkDavid T. Rubin, MD, F<strong>ACG</strong>Assess current options andrecommendations to treat IBD refractory toanti-TNF therapy.11:45 am Q & A12:00 noon Adjourn